VF
BIAF icon

Virtu Financial’s bioAffinity Technologies BIAF Stock Holding History

Virtu Financial’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
+11,113
New +$22.7K ﹤0.01% 1449

Other funds holding BIAF

JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtu Financial's BIAF Position: Q2 2026 in Review

Virtu Financial opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 11,113 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1449 among its holdings.

12 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Virtu Financial held 11,113 shares of bioAffinity Technologies worth $9K as of Q2 2026.
  • bioAffinity Technologies was a new Virtu Financial position in Q2 2026.
  • bioAffinity Technologies made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1449 holding.
  • 12 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.